Ori Biotech Cell & Gene Tech Expo August 2025: Cell Therapy

Cell and gene therapies are constrained by manufacturing complexities that drive up costs. Ori Biotech's IRO® platform is a proprietary, closed system designed to overcome these hurdles by fully automating and standardizing production. The platform's unique bellows-based bioreactor provides flexible mixing modalities that lead to superior biological performance, including improved cell growth and transduction efficiency. This efficiency can tangibly reduce costs by minimizing the need for expensive inputs like viral vectors. The system also features the innovative Ori Connect consumable, which creates sterile fluid paths without error-prone tube sealing and welding. This allows for seamless scaling from R&D to commercial production in a smaller, more efficient footprint.

Watch the full presentation from the Cell & Gene Tech Expo to explore the data behind this manufacturing evolution.